Inhibition of metastasis in a murine 4T1 breast cancer model by liposomes preventing tumor cell-platelet interactions.

Clinical & Experimental Metastasis
Jane WenzelIduna Fichtner

Abstract

The interaction between circulating tumor cells and blood components, mainly platelets, plays an important role during metastasis. In this study, we prepared liposomes containing the platelet aggregation inhibitor Cilostazol (Cil-L). The objective of this study was to investigate the effect of this Cil-L on platelet aggregation and complex formation with murine 4T1 breast cancer cells in vitro and to determine their anti-metastatic potency in a spontaneous metastasis model of 4T1 breast cancer. Cil-L significantly inhibited the aggregation of platelets by up to 78% and completely abolished the complex formation of 4T1 tumor cells in the presence of activated platelets in vitro. Intravenous (i.v.) injection of Cil-L into mice significantly reduced the aggregability of mouse platelets by 60% measured ex vivo. To gain deeper insight into the mode of metastasis formation in a spontaneous metastasis model, 4T1 breast cancer cells were transplanted into the mammary fad pad of mice and metastasis to the mouse lungs was investigated with regard to tumor cell settlement and metastatic growth. We could demonstrate that the formation of pulmonary metastases was significantly reduced by 55% when mice were treated intravenously with 100 nmo...Continue Reading

References

Nov 1, 1992·Cancer Metastasis Reviews·K V HonnJ D Crissman
Jan 1, 1984·Cancer Metastasis Reviews·G J Gasic
Feb 1, 1980·Journal of Pharmacological Methods·D C Cardinal, R J Flower
Mar 15, 1996·International Journal of Cancer. Journal International Du Cancer·I SaikiN Oku
Mar 20, 1998·International Journal of Cancer. Journal International Du Cancer·S MoreckiS Slavin
Jan 16, 1999·Journal of the National Cancer Institute·M HejnaC C Zielinski
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·L BorsigA Varki
Mar 16, 2001·Breast Cancer Research : BCR·G H HeppnerP M Shekhar
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Lubor BorsigAjit Varki
Sep 6, 2002·The American Journal of Pathology·Christopher W WongAbu-Bakr Al-Mehdi
Sep 12, 2002·Expert Opinion on Therapeutic Targets·John T Price, Erik W Thompson
Jun 9, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Vladimir Bobek, Josef Kovarík
Aug 15, 2006·Current Opinion in Urology·Andrea Mancuso, Cora N Sternberg
Dec 13, 2006·International Journal of Cancer. Journal International Du Cancer·Behjatolah Monzavi-KarbassiThomas Kieber-Emmons
Aug 12, 2008·BMC Cancer·Kai TaoG Gary Sahagian
Aug 14, 2008·Expert Review of Anticancer Therapy·Lubor Borsig
Oct 23, 2008·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Takashi Tsuruo, Naoya Fujita
Dec 23, 2008·International Journal of Pharmaceutics·Jane WenzelIduna Fichtner
Jun 27, 2009·Neurologia Medico-chirurgica·Tetsuyuki YoshimotoTakeshi Kashiwaba

❮ Previous
Next ❯

Citations

Nov 4, 2011·Current Opinion in Pharmacology·Isaac LevyConstantine A Stratakis
Dec 1, 2015·Pharmacology & Therapeutics·Belay Tesfamariam
Nov 3, 2010·Journal of Thrombosis and Haemostasis : JTH·N M Bambace, C E Holmes
Oct 10, 2013·The Journal of Obstetrics and Gynaecology Research·Xuegong MaFengxia Xue
Apr 28, 2017·International Journal of Molecular Sciences·Themmila KhamrangJoen-Rong Sheu
Mar 15, 2018·Annual Review of Biomedical Engineering·Eric LinMichael R King
Mar 24, 2015·Cellular and Molecular Bioengineering·Jiahe LiMichael R King
Jan 25, 2011·Nature Reviews. Cancer·Laurie J Gay, Brunhilde Felding-Habermann
Oct 16, 2018·Advanced Functional Materials·Man YingLiangfang Zhang
Mar 10, 2018·Frontiers in Oncology·Christiana NeophytouPanagiotis Papageorgis
Jun 22, 2018·International Journal of Molecular Sciences·Thanasekaran JayakumarJoen-Rong Sheu
Mar 1, 2019·Food & Nutrition Research·Nurul Elyani MohamadNoorjahan Banu Alitheen
Apr 23, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Sang Bong LeeYong Hyun Jeon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.